Washington [US], May 4 (ANI): In an exciting turn of events for fans of dystopian action adventures, the iconic 'The Maze Runner' franchise is primed for a revival. 20th Century Studios is set to ...

JPMorgan, which set a $30 price target, sees multiple catalysts for Maze, emphasizing the breadth of MZE829’s potential patient base and its differentiation from Vertex’s drug. Guggenheim set ...